Beta Thalassemia Major: Clinical Trials

19 trials for Beta Thalassemia Major, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 unknown, 1 not yet recruiting, 1 terminated. 9 Not applicable, 4 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 6, Unknown 2, Not yet recruiting 1
Phase 24Unknown 2, Completed 1, Terminated 1
Phase 32Unknown 2
Early Phase 11Withdrawn 1
Phase 11Unknown 1

Follow Beta Thalassemia Major: new trials by email Literature Review of Beta Thalassemia Major trials Research Report on Beta Thalassemia Major

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial
laughter yoga - Beta Thalassemia Major, Thalassemia Majors (Beta-Thalassemia Major)
Not applicableNot yet recruitingAtaturk University602025-06-012025-05-20
Iron Accumulation in Erythrocytes in Patients
Beta Thalassemia Major
CompletedAnkara City Hospital Bilkent1002024-10-202026-03-20
Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Thalassemia
Serum ferritin, Serum hepcidin - Liver Fibrosis, Beta Thalassemia Major
CompletedTanta University1002024-09-122025-09-04
Inspiratory Muscle Training in Children With Beta Thalasemia
inspiratory muscle training - Beta Thalassemia Major
Not applicableUnknownAhram Canadian University402024-06-062024-06-20
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
Bortezomib, Busulfan, Cyclophosphamide - Beta Thalassemia Major, Sickle Beta 0 Thalassemia
Early Phase 1WithdrawnM.D. Anderson Cancer Center2020-12-292024-10-24
ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19
Non applicable, is a patient registry - Hemoglobinopathies, Sickle Cell Disease
CompletedHospital Universitari Vall d'Hebron Research Institute6842020-04-152025-02-18
Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
Emeramide - Beta Thalassemia Major
Phase 2CompletedEmeraMed132019-11-212021-08-26
PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders
Sofosbuvir and Ledipasvir - HCV Infection, Beta Thalassemia Major
Phase 3UnknownAin Shams University242018-06-112023-03-06
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
Autologous CD34+ cells genetically modified - Beta Thalassemia Major
Phase 1 / Phase 2UnknownNanfang Hospital, Southern Medical University102017-09-152017-09-08
Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism
Interleukin-2, Donor Regulatory T-Lymphocytes - Beta Thalassemia Major
Not applicableUnknownFirst Affiliated Hospital of Guangxi Medical University302016-08-012018-08-28
Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C
Spirulina - Beta Thalassemia Major
Not applicableCompletedTanta University602015-12-012018-09-11
Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C
Spirulina - Beta Thalassemia Major
Not applicableCompletedTanta University602015-12-012019-04-10
the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children
Spirulina - Beta Thalassemia Major
Not applicableCompletedTanta University602015-10-012017-10-25
Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia
Spirulina, Amlodipine - Beta Thalassemia Major
Not applicableCompletedTanta University402015-04-012018-07-12
Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C
spirulina - Beta Thalassemia Major
Not applicableCompletedTanta University302015-03-012018-09-11
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Deferiprone - Beta Thalassemia Major
Phase 2 / Phase 3UnknownAin Shams University642014-07-012015-01-14
Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
serum ferritin and hemoglobin test - Beta Thalassemia Major
CompletedAga Khan University3672013-01-012019-05-13
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.
SOTATERCEPT (ACE-011) - Beta Thalassemia Major, Beta Thalassemia Intermedia
Phase 2TerminatedCelgene462012-10-102023-06-18
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
GCSF, Central venous line placement, Stem cell Collection (leukapheresis) - Beta Thalassemia Major, Congenital Anemias
Not applicableCompletedMemorial Sloan Kettering Cancer Center52008-04-012016-11-25

Narrower conditions

beta-Thalassemia (19)  ·  Anemia, Sickle Cell (2)  ·  Iron Overload (2)  ·  Anemia (1)  ·  Beta Thalassemia, Dominant Inclusion Body Type (1)  ·  COVID-19 (1)  ·  Delta-Beta Thalassemia (1)  ·  Elliptocytosis, Hereditary (1)  ·  Fatigue (1)  ·  Hemoglobin SC Disease (1)  ·  Hemoglobinopathies (1)  ·  Hepatitis C (1)  ·  Liver Cirrhosis (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Spherocytosis, Hereditary (1)

Broader conditions

Anemia, Hemolytic (19)  ·  Anemia, Hemolytic, Congenital (19)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (19)  ·  Genetic Diseases, Inborn (19)  ·  Hematologic Diseases (19)  ·  Hemic and Lymphatic Diseases (19)  ·  Anemia (18)  ·  Hemoglobinopathies (18)  ·  Thalassemia (18)  ·  Digestive System Diseases (2)  ·  Infections (2)  ·  Iron Metabolism Disorders (2)  ·  Liver Diseases (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Interventions

ACE-011 (1)  ·  Amlodipine (1)  ·  Antilymphocyte Serum (1)  ·  Bortezomib (1)  ·  Busulfan (1)  ·  CT-P10 (1)  ·  Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Deferiprone (1)  ·  Dexamethasone (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Interleukin-2 (1)  ·  Laughter Therapy (1)  ·  Leukapheresis (1)  ·  Mycophenolic Acid (1)

Sponsors

Tanta University (6)  ·  Ain Shams University (2)  ·  Aga Khan University (1)  ·  Ahram Canadian University (1)  ·  Ankara City Hospital Bilkent (1)  ·  Ataturk University (1)  ·  Celgene (1)  ·  EmeraMed (1)  ·  First Affiliated Hospital of Guangxi Medical University (1)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Nanfang Hospital, Southern Medical University (1)

Countries

Egypt (9)  ·  China (2)  ·  Turkey (Türkiye) (2)  ·  Albania (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Farid Boulad, MD (1)  ·  Kris M Mahadeo (1)  ·  Manal H El-Sayed, M.D (1)  ·  Mohamed R El-Shanshory, MD (1)  ·  Mohsen S Elalfy, professour (1)  ·  Sahar M El-Haggar, MD (1)

Results publications

PMID 37975597, PMID 29119631, PMID 34186262